Inessa Schwab Sauerbeck
Novartis Pharma GmbH
Inessa Schwab Sauerbeck is listed as Novartis Pharma GmbH. Inessa spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Multiple Sklerose”).
Compiled from published conference agendas; not yet confirmed by Inessa. Is this you? Claim this profile.
Sessions at 1 conference
DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026
- Multiple Sklerose Speaker